Glenmark Pharmaceuticals
GLENMARK.NS
$16.05
Share price
0.27%
Change (1 day)
28.47%
Change (1 year)
Categories
Revenue for Glenmark Pharmaceuticals (GLENMARK.NS)
Revenue in 2024 (TTM): $1.53 Billion USD
According to Glenmark Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is $1.53 Billion USD. an increase over the revenue in the year 2023 that were of $1.44 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Glenmark Pharmaceuticals from 2012 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $1.53 B | 6.69% |
| 2023 | $1.44 B | -1.94% |
| 2022 | $1.47 B | -9.42% |
| 2021 | $1.62 B | 13.15% |
| 2020 | $1.43 B | -1.46% |
| 2019 | $1.45 B | 6.7% |
| 2018 | $1.36 B | -3.45% |
| 2017 | $1.41 B | 8.6% |
| 2016 | $1.30 B | 20.2% |
| 2015 | $1.08 B | 2.64% |
| 2014 | $1.05 B | 11.63% |
| 2013 | $0.94 B | 6.64% |
| 2012 | $0.88 B |